Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma
- PMID: 28806937
- PMCID: PMC5556356
- DOI: 10.1186/s12885-017-3523-y
Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma
Abstract
Background: The levels of liver function tests (LFTs) are often used to assess liver injury and non-liver disease-related mortality. In our study, the relationship between pretreatment serum LFTs and overall survival (OS) was evaluated in esophageal squamous cell carcinoma (ESCC) patients.
Methods: Our purpose was to investigate the prognostic value of the preoperative alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in ESCC patients. A retrospective study was performed in 447 patients with ESCC, and follow-up period was at least 60 months until death. The prognostic significance of serum LFTs were determined by univariate and multivariate Cox hazard models.
Results: LFTs including ALT, AST, LSR, GGT, TBA and LDH were analyzed. Serum LSR (HR: 0.592, 95% CI = 0.457-0.768, p < 0.001 and GGT (HR: 1.507, 95% CI = 1.163-1.953, p = 0.002) levels were indicated as significant predictors of OS. The 5-year OS among patients with higher LSR levels was longer compared with those patients with decreased LSR levels, not only in the whole cohort but also in the subgroups stratified by pathological stage (T1-T2 subgroup, T3-T4 subgroup, N0 subgroup and M0 subgroup). We also found that patients with a higher GGT might predict worse OS than patients with a normal GGT, not only in the whole cohort but also in the subgroups stratified by pathological stage (T3-T4 subgroup and N1-N2 subgroup).
Conclusions: Both increased levels of LSR and decreased levels of GGT might predict shorter overall survival in ESCC patients. Our findings suggest that serum LSR and GGT levels could be used as a key predictor of survival in patients with ESCC.
Keywords: Alanine aminotransferase/aspartate aminotransferase ratio; Esophageal squamous cell carcinoma; Gamma glutamyltransferase; Overall survival; Prognosis.
Conflict of interest statement
Ethics approval and consent to participate
This study was approved by the Institute Research Ethics Committee of the Sun Yat-Sen University Cancer Center, Guangzhou, China. Each patients signed the informed consent.
Consent for publication
Not applicable.
Competing interests
The authors disclose no competing interests. There are no financial and non-financial competing interests (political, personal, religious, ideological, academic, intellectual, commercial or any other) to declare in relation to this.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures


Similar articles
-
Prognostic Effect of the PNI and LSR in Patients with Esophageal Squamous Cell Carcinoma Patients Receiving Radiotherapy.J Gastrointest Cancer. 2024 Nov 27;56(1):26. doi: 10.1007/s12029-024-01148-x. J Gastrointest Cancer. 2024. PMID: 39601941
-
The prognostic significance of serum gamma-glutamyltransferase levels and AST/ALT in primary hepatic carcinoma.BMC Cancer. 2019 Aug 27;19(1):841. doi: 10.1186/s12885-019-6011-8. BMC Cancer. 2019. PMID: 31455253 Free PMC article.
-
Prognostic significance of gamma-glutamyltransferase in patients with resectable esophageal squamous cell carcinoma.Dis Esophagus. 2015 Jul;28(5):496-504. doi: 10.1111/dote.12227. Epub 2014 Apr 27. Dis Esophagus. 2015. PMID: 24766310
-
Elevated liver enzymes and cardiovascular mortality: a systematic review and dose-response meta-analysis of more than one million participants.Eur J Gastroenterol Hepatol. 2019 May;31(5):555-562. doi: 10.1097/MEG.0000000000001353. Eur J Gastroenterol Hepatol. 2019. PMID: 30614883
-
Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies.Atherosclerosis. 2014 Sep;236(1):7-17. doi: 10.1016/j.atherosclerosis.2014.06.006. Epub 2014 Jun 23. Atherosclerosis. 2014. PMID: 24998934 Review.
Cited by
-
Prognostic Significance of the Lung Immune Prognostic Index in Patients with Resected Esophageal Squamous Cell Carcinoma.Cancer Manag Res. 2021 Mar 26;13:2811-2819. doi: 10.2147/CMAR.S298412. eCollection 2021. Cancer Manag Res. 2021. PMID: 33814930 Free PMC article.
-
Serum aspartate aminotransferase, a novel potential biomarker of prognosis in extranodal natural killer/T cell lymphoma, nasal type.Cancer Biomark. 2024;39(4):265-275. doi: 10.3233/CBM-230068. Cancer Biomark. 2024. PMID: 38108343 Free PMC article.
-
Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma.Cancer Cell Int. 2021 Sep 28;21(1):518. doi: 10.1186/s12935-021-02217-y. Cancer Cell Int. 2021. PMID: 34583688 Free PMC article.
-
The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study.PLoS One. 2020 Jan 24;15(1):e0226351. doi: 10.1371/journal.pone.0226351. eCollection 2020. PLoS One. 2020. PMID: 31978054 Free PMC article.
-
The Prognostic Value of Preoperative Serum D-dimer Levels After Surgical Resection of Thymic Epithelial Tumors.Cancer Control. 2022 Jan-Dec;29:10732748221129108. doi: 10.1177/10732748221129108. Cancer Control. 2022. PMID: 36373938 Free PMC article.
References
-
- Bedenne L, Michel P, Bouche O, Milan C, Mariette C, Conroy T, Pezet D, Roullet B, Seitz JF, Herr JP, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007;25(10):1160–1168. doi: 10.1200/JCO.2005.04.7118. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous